MiR-21 inhibits PTEN that causes an increase in AKT phosphorylation, which upregulates the downstream signaling genes of AKT that are required for tumor formation and increases the phosphorylation of STAT3 (p-STAT3); this gene network promotes hepatic lipid accumulation. The gene discussed is STAT3; the disease is neoplasm.